On
Haematology
The Haematology Department at Concord Hospital provides treatment and care for patients with blood cancers including leukaemia, lymphoma and myeloma, and other blood disorders such as blood clots and anaemia.
Our patients receive care from a multidisciplinary team of haematologists, specialist nurses, pathologists, radiologists, radiation oncologists, allied health clinicians and clinical research staff. We work closely to ensure a coordinated, holistic approach to patient treatment.
With support from local community organisation Foundation for A Bloody Great Cause, the Haematology Department conducts world leading clinical trials, giving blood cancer and other haematology patients access to innovative medicines.
Our team
Our Specialists |
|
|---|---|
| Head of Department, Haematologist | Dr Emma Verner |
| Director of Cancer Services and Palliative Care, Haematologist | Clinical Associate Professor Ilona Cunningham |
| Haematologist | Professor Judith Trotman |
| Head of Discovery and Translational Research, Haematologist | Associate Professor Vivien Chen |
| Director of Haematology Clinical Research Unit, Haematologist | Dr Nicole Wong Doo |
| Deputy Head of Department, Haematologist | Dr Robin Gasiorowski |
| Head of Laboratory Haematology, Haematologist | Dr Riana van der Linde |
| Haematologist | Dr Ibrahim Tohidi-Esfahani |
| Haematologist | Dr Marc Ellis |
| Director Bone Marrow Transplant and Apheresis Unit, Haematologist | Dr Janlyn Falconer |
Our Nurses |
|
| Nurse Practitioner, Bone Marrow Transplant and Apheresis | Elizabeth Newman |
| Clinical Nurse Consultant, Haematology |
|
Appointments and referrals
A referral from a General Practitioner (GP) or specialist is required for all appointments. Urgent referrals should be discussed with the haematology registrar or consultant on call.
We recommend that you provide a named referral to one of our haematologists.
All patient referrals are triaged within 24 hours to be seen by a haematologist in order of medical need.
There are no out-of-pocket costs for Medicare-eligible patients.
General Practitioners (GP) can visit HealthPathways Sydney for up-to-date information on common conditions in haematology and referral information.
| Location | How to Refer |
|---|---|
|
Outpatient Clinics
|
Phone: 02 9767 5757 Fax: 02 9767 7650 Email: SLHD-ConcordHaematologyAdmin@health.nsw.gov.au Operating days: Mondays, Tuesdays, Wednesdays and Fridays between 8.30am to 4.30pm |
|
Croydon Health Centre
|
Phone: 02 9767 5757 Fax: 02 9767 7650 Email: SLHD-ConcordHaematologyAdmin@health.nsw.gov.au Operating day: Friday morning |
Our research
Laboratory and clinical researchers find treatments and cures for patients.
Our research mission is to:
- ensure quality, ethically sound clinical trials are the standard of care
- provide patients with access to emerging therapies through a diverse portfolio of quality trials
- contribute independently to evidence-based medicine
- better understand how blood diseases develop
- produce effective new treatments for patients with blood cancers and blood clots
| Basic laboratory | Basic laboratory bench work comes up with ideas for innovative ways to treat patients |
|---|---|
| Translational research | Translational research gets these ideas into clinical trials, where researchers partner with patients to evaluate the safety and benefits of new treatments and medicines |
| Clinical Trials | Clinical trials provide insights on what needs further research back in the laboratory |
This bench-to-bedside research cycle leads to new and innovative treatments and cures.
Visit Concord Haematology Research for more information on our research achievements, team, grants and publications.
Laboratory research
The Haematology Department's laboratory research seeks to better understand how blood clots develop, to help develop new treatments for our patients.
Associate Professor Vivien Chen is the Laboratory Leader for the Platelet and Thrombosis Research Laboratory at the ANZAC Research Institute. This team is working to improve health outcomes for patients with thrombosis (blood clots), by developing new diagnostics and drug therapies for Cardiovascular and Venous Thrombosis.
Clinical research
The Clinical Research Unit at Concord Hospital's Department of Haematology was established in 2005. It is now one of the largest clinical trials units in Australia – the largest clinical research unit for blood cancers in NSW.
The team at Concord Haematology's Clinical Research Unit includes haematologist clinician researchers, research nurses and data managers who have built a broad portfolio of clinical trials across the spectrum of blood cancers at Concord Hospital.
They conduct world leading, patient centred clinical trials to access and develop innovative therapies for leukaemia, lymphoma, myeloma and other blood disorders – cutting edge research which evaluates the safety and benefits of new medicines.
Clinical trials improve outcomes for patients and have greatly increased the cure rates for many blood cancers over recent years. By participating in these world leading clinical trials, hundreds of patients at Concord Hospital have benefited greatly from many new and innovative treatments, long before they are funded by the Australian Government.
For these patients and their families, participation in research offers them greater hope for a cure and a better quality of life.
To contact the Haematology Clinical Research Unit phone 02 9767 6348 or email SLHD-ConcordHaematologyClinicalResearch@health.nsw.gov.au
Clinical trials
A comprehensive list of currently recruiting clinical trials across NSW and ACT is provided through the handy ClinTrial Refer website and mobile app. It provides information that is searchable by disease, location, trial status and sponsor.
The App is available for doctors and patients, free of charge through the iTunes App Store or Google Play.
How you can support us
The Foundation for A Bloody Great Cause raises funds and advocates for the world leading haematology clinical research at Concord Haematology.
Make a donation